Evidence map›Paper›PMID 30176236›Full record

ArticleInternational journal for parasitology2019

Insights into the evolution and drug susceptibility of Babesia duncani from the sequence of its mitochondrial and apicoplast genomes.

Azan Z Virji, Jose Thekkiniath, Wenxiu Ma, Lauren Lawres, James Knight, Andrea Swei, Karine Le Roch, Choukri Ben Mamoun

Abstract read
In one paragraph

Article in International journal for parasitology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Mitochondrial Genome Analysis ofVeterinary sciences · 2024
    Article
  5. Article
  6. Transfection ofBio-protocol · 2024
    Article
  7. The Complete Mitochondrial Genome Sequence ofLife (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Transfusion-transmittedJournal of clinical microbiology · 2023
    Review
  10. Article
  11. Establishment of a Transient and Stable Transfection System forFrontiers in cellular and infection microbiology · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Azan Z VirjiDepartment of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT 06520, USA.
Jose ThekkiniathDepartment of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT 06520, USA.
Wenxiu MaDepartment of Statistics, University of California, 900 University Avenue, Riverside, CA 92521, USA.
Lauren LawresDepartment of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT 06520, USA.
James KnightDepartment of Genetics, Yale School of Medicine, New Haven, CT 06520, USA.
Andrea SweiDepartment of Biology, San Francisco State University, 1600 Holloway Ave, San Francisco, CA 94132, USA.
Karine Le RochDepartment of Cell Biology & Neuroscience, 900 University Avenue, University of California, Riverside, CA 92521, USA.
Choukri Ben MamounDepartment of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT 06520, USA. Electronic address: choukri.benmamoun@yale.edu.

Funding

Development of endochin-like quinolones for babesiosis therapyR01AI123321 · NIAID · YALE UNIVERSITY · PI BEN MAMOUN, CHOUKRI · 2017 to 2020
$2.7M
Function and Inhibition of Plasmodium Lipid DecarboxylasesR01AI097218 · NIAID · YALE UNIVERSITY · PI BEN MAMOUN, CHOUKRI · 2012 to 2016
$2.0M
Synthesis and Study of Complex Antiproliferative and Antimalarial Natural ProductsR01GM110506 · NIGMS · YALE UNIVERSITY · PI HERZON, SETH B. · 2015 to 2018
$1.2M
High Performance Computing Instrumentation for the Yale Center for Genome AnalysiS10OD018521 · OD · YALE UNIVERSITY · PI MANE, SHRIKANT M · 2015 to 2015
$890k
Acquisition of a Scalable Storage Cluster for Data Intensive NIH ResearchS10OD016290 · OD · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI GIRKE, THOMAS · 2014 to 2014
$593k
An antigen-detection assay to diagnose Babesia microti infectionR43AI136118 · NIAID · L2 DIAGNOSTICS, LLC · PI LEDIZET, MICHEL · 2018 to 2018
$300k
Howard Hughes Medical InstituteNIAID NIH HHS R01 AI097218NIAID NIH HHS R01 AI123321NIAID NIH HHS R43 AI136118NIGMS NIH HHS R01 GM110506NIH HHS S10 OD016290NIH HHS S10 OD018521
6 · The paper itself

Abstract

Babesia microti and Babesia duncani are the main causative agents of human babesiosis in the United States. While significant knowledge about B. microti has been gained over the past few years, nothing is known about B. duncani biology, pathogenesis, mode of transmission or sensitivity to currently recommended therapies. Studies in immunocompetent wild type mice and hamsters have shown that unlike B. microti, infection with B. duncani results in severe pathology and ultimately death. The parasite factors involved in B. duncani virulence remain unknown. Here we report the first known completed sequence and annotation of the apicoplast and mitochondrial genomes of B. duncani. We found that the apicoplast genome of this parasite consists of a 34 kb monocistronic circular molecule encoding functions that are important for apicoplast gene transcription as well as translation and maturation of the organelle's proteins. The mitochondrial genome of B. duncani consists of a 5.9 kb monocistronic linear molecule with two inverted repeats of 48 bp at both ends. Using the conserved cytochrome b (Cytb) and cytochrome c oxidase subunit I (coxI) proteins encoded by the mitochondrial genome, phylogenetic analysis revealed that B. duncani defines a new lineage among apicomplexan parasites distinct from B. microti, Babesia bovis, Theileria spp. and Plasmodium spp. Annotation of the apicoplast and mitochondrial genomes of B. duncani identified targets for development of effective therapies. Our studies set the stage for evaluation of the efficacy of these drugs alone or in combination against B. duncani in culture as well as in animal models.

Indexed as

Drug ResistanceEvolution, MolecularGenome, MitochondrialGenome, ProtozoanAnimalsBabesiaHumansMolecular Sequence AnnotationUnited StatesWhole Genome SequencingAnnotationApicoplastBabesiosisDrug targetsGenomeMitochondriaSequencing

Identifiers

PMID30176236
PMCPMC6395566

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.